Abstract
Introduction
The treatment of amblyopia is a large part of the pediatric ophthalmology and orthoptic practice. The Amblyopia Treatment Studies (ATS) have tried to answer questions about which treatments work for different types of amblyopia and which treatments work the best.
Methods
Each of the ATS articles were examined for strengths and weaknesses with particular emphasis on the ATS1, patching versus atropine study.
Results
Many strengths and weaknesses were found. As indicated by this article's title, the weaknesses were emphasized.
Conclusions
These studies had, as all prospective studies do, strict inclusion criteria that hampered the study by limiting the included patients. However, in some areas the study's methodology was not strict enough, making the results subject to question.